Cargando…
Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation
The clinical implementation of magnetic hyperthermia has experienced little progress since the first clinical trial was completed in 2005. Some of the hurdles to overcome are the reliable production of magnetic nanoparticles with controlled properties and the control of the temperature at the target...
Autores principales: | Luengo, Yurena, Díaz-Riascos, Zamira V., García-Soriano, David, Teran, Francisco J., Artés-Ibáñez, Emilio J., Ibarrola, Oihane, Somoza, Álvaro, Miranda, Rodolfo, Schwartz, Simó, Abasolo, Ibane, Salas, Gorka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331462/ https://www.ncbi.nlm.nih.gov/pubmed/35893782 http://dx.doi.org/10.3390/pharmaceutics14081526 |
Ejemplares similares
-
Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells
por: Gener, Petra, et al.
Publicado: (2019) -
Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide
por: Cámara-Sánchez, Patricia, et al.
Publicado: (2022) -
Smart Modification on Magnetic Nanoparticles Dramatically Enhances Their Therapeutic Properties
por: Lafuente-Gómez, Nuria, et al.
Publicado: (2021) -
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
por: Pesarrodona, Mireia, et al.
Publicado: (2019) -
The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers
por: Andrade, Fernanda, et al.
Publicado: (2023)